These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18260982)

  • 1. [Long-term follow-up of the West of Scotland Coronary Prevention Study].
    Liakishev AA
    Kardiologiia; 2007; 47(12):65-6. PubMed ID: 18260982
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term follow-up of the West of Scotland Coronary Prevention Study.
    McEvoy JW; Margey R; Blake GJ
    N Engl J Med; 2008 Jan; 358(2):193; author reply 194-5. PubMed ID: 18184967
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term follow-up of the West of Scotland Coronary Prevention Study.
    DeFilippis AP; Bansal S; Blumenthal RS
    N Engl J Med; 2008 Jan; 358(2):194; author reply 194-5. PubMed ID: 18193527
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term follow-up of the West of Scotland Coronary Prevention Study.
    Tsubokura M; Kami M
    N Engl J Med; 2008 Jan; 358(2):193-4; author reply 194-5. PubMed ID: 18193526
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pravastatin and the development of diabetes mellitus. Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study].
    Comaschi MA; Menozzi F
    Ital Heart J Suppl; 2001 May; 2(5):556-8. PubMed ID: 11388336
    [No Abstract]   [Full Text] [Related]  

  • 6. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
    Lim PO; Yee KM
    Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
    [No Abstract]   [Full Text] [Related]  

  • 7. [WOSCOPS [West of Scotland Coronary Prevention Study]].
    Furutani N; Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():387-92. PubMed ID: 11347100
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term follow-up of the West of Scotland Coronary Prevention Study.
    Ford I; Murray H; Packard CJ; Shepherd J; Macfarlane PW; Cobbe SM;
    N Engl J Med; 2007 Oct; 357(15):1477-86. PubMed ID: 17928595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study.
    Hague WE; Simes J; Kirby A; Keech AC; White HD; Hunt D; Nestel PJ; Colquhoun DM; Pater H; Stewart RA; Sullivan DR; Thompson PL; West M; Glasziou PP; Tonkin AM;
    Circulation; 2016 May; 133(19):1851-60. PubMed ID: 27016105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
    Elam MB; Cushman W; Applegate WB; Heimberg M
    Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.
    Simes J; Furberg CD; Braunwald E; Davis BR; Ford I; Tonkin A; Shepherd J
    Eur Heart J; 2002 Feb; 23(3):207-15. PubMed ID: 11792135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computerised record linkage: compared with traditional patient follow-up methods in clinical trials and illustrated in a prospective epidemiological study. The West of Scotland Coronary Prevention Study Group.
    J Clin Epidemiol; 1995 Dec; 48(12):1441-52. PubMed ID: 8543958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol and coronary heart disease: new data from the WOSCOP Study.
    Poli A
    Pharmacol Res; 1997 Mar; 35(3):171-2. PubMed ID: 9229403
    [No Abstract]   [Full Text] [Related]  

  • 14. Lessons learned from the prospective pravastatin pooling project.
    Byington RP; Sacks FM
    Curr Atheroscler Rep; 2004 Sep; 6(5):366-74. PubMed ID: 15296703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The West of Scotland Coronary Prevention Study: a trial of cholesterol reduction in Scottish men.
    Shepherd J
    Am J Cardiol; 1995 Sep; 76(9):113C-117C. PubMed ID: 7572679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
    LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
    Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at Risk.
    Drewes YM; Poortvliet RK; Blom JW; de Ruijter W; Westendorp RG; Stott DJ; Blom HJ; Ford I; Sattar N; Wouter Jukema J; Assendelft WJ; de Craen AJ; Gussekloo J
    J Am Geriatr Soc; 2014 Feb; 62(2):213-21. PubMed ID: 24447238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study.
    Brouilette SW; Moore JS; McMahon AD; Thompson JR; Ford I; Shepherd J; Packard CJ; Samani NJ;
    Lancet; 2007 Jan; 369(9556):107-14. PubMed ID: 17223473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance and adverse event withdrawal: their impact on the West of Scotland Coronary Prevention Study.
    Eur Heart J; 1997 Nov; 18(11):1718-24. PubMed ID: 9402445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease.
    Ledmyr H; McMahon AD; Ehrenborg E; Nielsen LB; Neville M; Lithell H; MacFarlane PW; Packard CJ; Karpe F;
    Circulation; 2004 May; 109(19):2279-84. PubMed ID: 15136504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.